Biotech

Celgene Can't Expand Revlimid Approval Into Non-Hodgkin Lymphoma Just Yet

Celgene Can't Expand Revlimid Approval Into Non-Hodgkin Lymphoma Just Yet

Gilead Lowers Product Sales Guidance on Weak Hepatitis C Sales

Gilead Lowers Product Sales Guidance on Weak Hepatitis C Sales

Gilead Readying for Earnings Report

Gilead Readying for Earnings Report

What to Watch This Week: Apple, Facebook, Alphabet Report Earnings; Federal Reserve Meeting

What to Watch This Week: Apple, Facebook, Alphabet Report Earnings; Federal Reserve Meeting

Jim Cramer on Tesla: Elon Musk is a Visionary, Numbers Tell a Different Story

Jim Cramer on Tesla: Elon Musk is a Visionary, Numbers Tell a Different Story

Relypsa Stock Surges on $1.53 Billion Galenica Takeover Offer

Relypsa Stock Surges on $1.53 Billion Galenica Takeover Offer

Biogen Shares Climb on Earnings Beat, CEO Departure

Biogen Shares Climb on Earnings Beat, CEO Departure

13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys

13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys

Here's Why Jim Cramer Is Positive About Valeant Pharmaceuticals

Here's Why Jim Cramer Is Positive About Valeant Pharmaceuticals

Futures Point Downward for U.S. Markets as Asia Opens Lower

Futures Point Downward for U.S. Markets as Asia Opens Lower